Gapping down
In reaction to earnings/guidance:
- KFY -6.4%, SPWH -6%, GEF -5.9%, GTE -4.8%, VRNT -2.4% (also authorizes new $200 mln share repurchase program)
Other news:
- RLMD -37.5% (announces top-line results from Phase 3 RELIANCE I Trial for REL-1017)
- DSGN -25.5% (reports data from trial of DT-216)
- CUTR -13.4% (pricing of $100 mln aggregate principal amount of 4.00% convertible senior notes due 2029)
- CHEF -6.9% ($250 mln convertible notes offering)
- NEP -5.2% ($500 mln convertible notes offering)
- UNIT -3% (RVMD to regain global rights to RMC-4630 following SNY's termination of collaboration)
- SNY -2.6% (RVMD to regain global rights to RMC-4630 following SNY's termination of collaboration)
- TIL -2.5% (announced a reprioritization of its clinical programs to focus on development of its CoStAR-TIL product candidates; Reducing U.S. headcount by approximately 60%)
- CABA -2% (offering of 6,213,776 shares at a price of $5.52/share for aggregate proceeds of $35 mln)
- BVS -1.8% (announces restructuring)
Analyst comments:
- APP -0.9% (downgraded to Neutral from Buy at BTIG Research)